Osavampator
N/A
Report date: 2026/04/24 20:01:59
NME
Base Information
Drug NameOsavampator
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[23]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesNeurocrine Biosciences Inc
Inactive CompaniesMillennium Pharmaceuticals IncTakeda Pharmaceutical Co Ltd
Active Indications
Inactive Indications